跳至主要内容
临床试验/JPRN-UMIN000010762
JPRN-UMIN000010762已完成未知

Effects of erythropoiesis stimulating agentin on heart failure patients with reduced left ventricular function and the cardiorenal anemia syndrome - Effects of erythropoiesis stimulating agent on heart failure patients

Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2013年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. uncontrolled hypertension (>160/100 mmHg) 2. previous history of cardiovascular disease within 3 months 3. new-onset of atrial fibrillation and atrial flutter within one month 4. Cr>3mg/dl 5. renal transplantation within 6 months, or chemo and radiation therapy within 12 months. Previous history of malignant disease, hematological disorder. 6. allergy of ESA

研究者

发起方
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine

相似试验